1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow brca2 Mutation Carrier: new trials by email Literature Review of brca2 Mutation Carrier trials Research Report on brca2 Mutation Carrier
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation letrozole, Placebo - brca1 Mutation Carrier, brca2 Mutation Carrier | Phase 3 | Completed | UNICANCER | 170 | 2008-05-01 | 2024-07-01 |
Breast Neoplasms (1) · Hereditary Breast and Ovarian Cancer Syndrome (1)
Adnexal Diseases (1) · Breast Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Syndromes, Hereditary (1)
Letrozole (1)
UNICANCER (1)
France (1)
Pascal Pujol, MD (1)